Orexo AB Release: First Patient Dosed in New Phase III Study Targeted Towards a Future Clinical Indication Expansion for Zubsolv
6/17/2013
More...
|
MannKind Corporation (MNKD) Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 2 Diabetes
6/17/2013
More...
|
Gilead Sciences, Inc. (GILD) Announces Interim Phase 2 Data for Idelalisib Showing Response in Refractory Indolent Non-Hodgkin's Lymphoma
6/17/2013
More...
|
Acetylon Pharmaceuticals Presents Encouraging Safety and Clinical Response Data from Ongoing Clinical Trials of ACY-1215 for the Treatment of Multiple Myeloma
6/17/2013
More...
|
Versartis, Inc. Presents Positive Results From Its First Pediatric Clinical Study of Novel Long-Acting Growth Hormone Treatment at ENDO Annual Meeting
6/17/2013
More...
|
Boehringer Ingelheim Corporation Release: New Long-Term Data Reinforce Safety Profile of Pradaxa® for Stroke Prevention in AF
6/17/2013
More...
|
Celgene International Sárl (CELG) Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now Indicated as a Treatment for Patients With Rare Form of Blood Disease
6/17/2013
More...
|
Siemens Healthcare Diagnostics to Create Companion Diagnostic Test for In-Development Janssen Heart Failure Drug
6/17/2013
More...
|
EU Grants EUR 6M to the Clinical Development of Athera Biotechnologies's Cardiovascular Disease Antibody Therapy
6/17/2013
More...
|
Karolinska Development AB: EU Grants EUR 6 Million to the Clinical Development of Athera Biotechnologies' Cardiovascular Disease Antibody Therapy
6/17/2013
More...
|
Takeda Pharmaceutical Co. Ltd. (TKPYY) Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
6/17/2013
More...
|
Boehringer Ingelheim Corporation Release: New Long-Term Data Published in Circulation Reinforce Safety Profile of Pradaxa® (dabigatran etexilate mesylate)
6/14/2013
More...
|
Novo Nordisk A/S (NVO) Release: Victoza® (Liraglutide [rDNA Origin] Injection) Safety Profile Further Supported at Scientific Workshop on Pancreatitis, Diabetes and Pancreatic Cancer
6/14/2013
More...
|
Inovio Pharmaceuticals (INO)'s Universal H7N9 DNA Vaccine Generates First Protective Antibody Responses Against Virulent H7N9 Virus in 100% of Vaccinated Animals
6/14/2013
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Announces AZILECT® (Rasagiline Tablets) Data to be Presented at the 2013 International Congress of Parkinson’s Disease and Movement Disorders
6/14/2013
More...
|